West Oak Capital LLC trimmed its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 9.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 750 shares of the company’s stock after selling 75 shares during the period. West Oak Capital LLC’s holdings in Clorox were worth $122,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in CLX. Prospera Private Wealth LLC purchased a new position in Clorox in the third quarter valued at about $27,000. Continuum Advisory LLC raised its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Quarry LP lifted its stake in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Carolina Wealth Advisors LLC bought a new position in Clorox during the third quarter valued at $48,000. Finally, Friedenthal Financial purchased a new stake in Clorox in the third quarter worth $49,000. 78.53% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research analysts have recently commented on CLX shares. Barclays upped their price target on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday, November 1st. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and increased their target price for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their target price for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $155.00 to $157.00 in a research note on Tuesday, January 7th. Finally, StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $157.46.
Clorox Price Performance
NYSE:CLX opened at $157.32 on Tuesday. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The stock has a fifty day moving average of $164.55 and a 200 day moving average of $156.00. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The firm has a market capitalization of $19.47 billion, a price-to-earnings ratio of 54.82, a P/E/G ratio of 3.04 and a beta of 0.42.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter last year, the company posted $0.49 EPS. On average, research analysts expect that The Clorox Company will post 6.85 EPS for the current fiscal year.
Clorox Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.10%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is currently 170.03%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Cintas: Trade Uncertainty Creates a Buy-the-Dip Opportunity
- Using the MarketBeat Stock Split Calculator
- 3 Stocks to Benefit From China’s Rare Earth Export Ban on U.S.
- Golden Cross Stocks: Pattern, Examples and Charts
- Why Goldman Sachs Just Upgraded These 3 Stocks and What It Means
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.